CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 27.86% | +7.77% | — | |
| 2 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 19.11% | -4.55% | +94.36% | |
| 3 | ZBIO | Zenas Biopharma INC | Stock-Other | 15.77% | -15.14% | — | |
| 4 | MLYS | Mineralys Therapeutics INC | Stock-Other | 11.59% | -3.40% | -32.42% | |
| 5 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 7.84% | +1.05% | — | |
| 6 | DSGN | Design Therapeutics INC | Stock-Other | 7.11% | -1.08% | — | |
| 7 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 5.83% | -3.10% | — | |
| 8 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.20% | +0.46% | — | |
| 9 | ALMS | Alumis INC | Stock-Other | 1.13% | +2.01% | — | |
| 10 | NKTX | Nkarta INC | Stock-Other | 1.00% | -0.10% | — | |
| 11 | OCS | Oculis Holding AG | Stock-Other | 0.82% | +0.05% | — | |
| 12 | ✓ | Engene Holdings INC | Stock-Other | 0.74% | -0.40% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | +9.9% | +94.36% | Add |
| 2 | ZBIO | Zenas Biopharma INC | +5.8% | — | Unchanged |
| 3 | DSGN | Design Therapeutics INC | +0.6% | — | Unchanged |
| 4 | ORKA | Oruka Therapeutics INC | +0.1% | — | Unchanged |
| 5 | ✓ | Engene Holdings INC | -0.1% | — | Unchanged |
| 6 | NKTX | Nkarta INC | -0.6% | — | Unchanged |
| 7 | OCS | Oculis Holding AG | -0.8% | — | Unchanged |
| 8 | MLYS | Mineralys Therapeutics INC | -1.2% | -32.42% | Trim |
| 9 | ALMS | Alumis INC | -2% | — | Unchanged |
| 10 | SPRY | Ars Pharmaceuticals INC | -7.1% | — | Unchanged |
| 11 | ACLXGBX | Arcellx INC | -11.7% | — | Unchanged |
| 12 | ORIC | Oric Pharmaceuticals INC | — | NEW | New buy |
| 13 | KALAEUR | Kala Bio INC | — | EXIT | Sold out |